Catalyst calendar
The repricing schedule is mostly public if you actually look at it.
AllI · Sterile fill-finish capacityII · Stoppers, syringes & drug-contact componentsIII · Pharmaceutical glass & vialsIV · Bioprocessing consumables & resinsV · API & small-molecule reshoringVI · CDMO capacity & the China exodusVII · Peptide & oligonucleotide manufacturingVIII · Sterile injectables & shortage economicsIX · Analytical instruments & QC releaseX · Private giants & exposure vehicles
July 2026
- 28mediumEarningsGLWCorning Q2 2026 earningsLife Sciences segment commentary and any Velocity vial/pharma tubing color sizes Corning's exposure to the glass chokepoint, though the print is dominated by optical/AI-glass.
August 2026
- 04mediumEarningsSTVNStevanato Group Q2 2026 earningsTests the high-value-solutions mix ramp and GLP-1 demand, plus progress on the BARDA-funded Fishers, IN vial lines turning gross-margin positive.
- 12mediumEarningsSHTPYSCHOTT Pharma Q3 FY2026 quarterly statementReads through on high-value/RTU vial and syringe demand and the ramp of the newly inaugurated Lebanon, PA capacity against the 2-5% FY2026 growth guide.
December 2026
- 18highPolicyBIOSECURE Act OMB 'companies of concern' initial list deadline (one year from enactment)Frames the US-onshoring tailwind backing BARDA-funded domestic vial capacity, even though the Act targets Chinese biotech CDMO services rather than glass packaging directly.